UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Brostallicin (PNU-166196) - a new DNA minor groove binder that retains sensitivity in DNA mismatch repair-deficient tumour cells

British journal of cancer, 2003-10, Vol.89 (8), p.1559-1565

2003

Volltextzugriff (PDF)

Blood glutathione as a surrogate marker of cancer tissue glutathione S-transferase activity in non-small cell lung cancer and squamous cell carcinoma of the head and neck

European journal of cancer (1990), 2003-05, Vol.39 (7), p.1019-1029

2003

Volltextzugriff (PDF)

Estimation of the haematological toxicity of minor groove alkylators using tests on human cord blood cells

British journal of cancer, 1997, Vol.75 (6), p.878-883

1997

Volltextzugriff (PDF)

α-Bromoacryloyl derivative of distamycin A (PNU 151807) : a new non-covalent minor groove DNA binder with antineoplastic activity

British journal of cancer, 1999-06, Vol.80 (7), p.991-997

1999

Volltextzugriff (PDF)

Predicting the maximum-tolerated dose of PNU-159548 (4-demethoxy-3′-deamino-3′-aziridinyl-4′-methylsulphonyl-daunorubicin) in humans using CFU-GM clonogenic assays and prospective validation

European journal of cancer (1990), 2003-03, Vol.39 (5), p.675-683

2003

Volltextzugriff (PDF)

Formation and Antitumor Activity of PNU-159682, A Major Metabolite of Nemorubicin in Human Liver Microsomes

Clinical cancer research, 2005-02, Vol.11 (4), p.1608-1617

2005

Volltextzugriff (PDF)

Ongoing phase I and II studies of novel anthracyclines

Cardiovascular toxicology, 2007-06, Vol.7 (2), p.75-79

2007

Volltextzugriff (PDF)

Cytotoxic α-Halogenoacrylic Derivatives of Distamycin A and Congeners

Journal of medicinal chemistry, 2004-05, Vol.47 (10), p.2611-2623

2004

Volltextzugriff (PDF)

Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin

British journal of cancer, 1986-09, Vol.54 (3), p.515-518

1986

Volltextzugriff (PDF)

Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione

Cancer research (Chicago, Ill.), 2002-04, Vol.62 (8), p.2332-2336

2002

Volltextzugriff (PDF)

Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studies

Bioorganic & medicinal chemistry, 2004-07, Vol.12 (14), p.3911-3921

2004

Volltextzugriff (PDF)

Brostallicin: a new concept in minor groove DNA binder development

Anti-cancer drugs, 2004-01, Vol.15 (1), p.1-6

2004

Volltextzugriff (PDF)

Decreased tyrosine phosphorylation in tumour cells resistant to FCE 24517 (tallimustine)

British journal of cancer, 1995-12, Vol.72 (6), p.1504-1508

1995

Volltextzugriff (PDF)

4-Demethoxy-3′-deamino-3′-aziridinyl-4′-methylsulphonyl-daunorubicin (PNU-159548): A promising new candidate for chemotherapeutic treatment of osteosarcoma patients

European journal of cancer (1990), 2005-09, Vol.41 (14), p.2184-2195

2005

Volltextzugriff (PDF)

Cytotoxic α-bromoacrylic derivatives of distamycin analogues modified at the amidino moiety

Bioorganic & medicinal chemistry letters, 2000-06, Vol.10 (11), p.1273-1276

2000

Volltextzugriff (PDF)

Sequence-specific DNA alkylation of novel tallimustine derivatives

Anti-cancer drug design, 1998-04, Vol.13 (3), p.193

1998

Volltextzugriff (PDF)

Influence of lipophilicity on cytotoxicity of anthracyclines in LoVo and LoVo/Dx human cell lines

Anti-cancer drug design, 1991-11, Vol.6 (5), p.385

1991

Volltextzugriff (PDF)

Cytotoxic alpha-Bromoacrylic derivatives of low molecular weight

Bioorganic & medicinal chemistry letters, 2002-06, Vol.12 (11), p.1467-1471

2002

Volltextzugriff (PDF)

Doxorubicin Activity Is Enhanced by Hyperthermia in a Model of Ex Vivo Vascular Perfusion of Human Colon Carcinoma

World journal of surgery, 2003-06, Vol.27 (6), p.640-646

2003

Volltextzugriff (PDF)

4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms

Cancer research (Chicago, Ill.), 2001-03, Vol.61 (5), p.1991-1995

2001

Volltextzugriff (PDF)

Ring-B modified anthracyclines

Current pharmaceutical design, 1999-03, Vol.5 (3), p.217-227

1999

Volltextzugriff (PDF)

Pharmacological and toxicological aspects of 4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548) : A novel antineoplastic agent

Cancer research (Chicago, Ill.), 2001-03, Vol.61 (5), p.1983-1990

2001

Volltextzugriff (PDF)

Cellular and molecular pharmacology of 4'-epidoxorubicin in HeLa cells: comparison with its parent drug, doxorubicin

Journal of cancer research and clinical oncology, 1989-01, Vol.115 (4), p.373-378

1989

Volltextzugriff (PDF)

DNA polymerases and DNA topoisomerases as targets for the development of anticancer drugs

Anticancer research, 1986-09, Vol.6 (5), p.935

1986

Volltextzugriff (PDF)

Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivatives

Journal of medicinal chemistry, 1989-04, Vol.32 (4), p.774-778

1989

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(38)

Sprache

Englisch
(37)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(32)
Science & Technology
(32)
Biological And Medical Sciences
(26)
Medical Sciences
(26)
Pharmacology. Drug Treatments
(24)
Animals
(22)
Antineoplastic Agents
(21)
Oncology
(20)
Mice
(17)
General Aspects
(15)
Pharmacology & Pharmacy
(15)
Antineoplastic Agents - Pharmacology
(10)
Cell Survival - Drug Effects
(10)
Chemistry, Medicinal
(10)
Female
(10)
Structure-Activity Relationship
(9)
Doxorubicin - Pharmacology
(8)
Drug Screening Assays, Antitumor
(8)
Tumor Cells, Cultured
(8)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Brostallicin (PNU-166196) - a new DNA minor groove binder that retains sensitivity in DNA mismatch repair-deficient tumour cells

Blood glutathione as a surrogate marker of cancer tissue glutathione S-transferase activity in non-small cell lung cancer and squamous cell carcinoma of the head and neck

Estimation of the haematological toxicity of minor groove alkylators using tests on human cord blood cells

α-Bromoacryloyl derivative of distamycin A (PNU 151807) : a new non-covalent minor groove DNA binder with antineoplastic activity

Predicting the maximum-tolerated dose of PNU-159548 (4-demethoxy-3′-deamino-3′-aziridinyl-4′-methylsulphonyl-daunorubicin) in humans using CFU-GM clonogenic assays and prospective validation

Formation and Antitumor Activity of PNU-159682, A Major Metabolite of Nemorubicin in Human Liver Microsomes

Ongoing phase I and II studies of novel anthracyclines

Cytotoxic α-Halogenoacrylic Derivatives of Distamycin A and Congeners

Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin

Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione

Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studies

Brostallicin: a new concept in minor groove DNA binder development

Decreased tyrosine phosphorylation in tumour cells resistant to FCE 24517 (tallimustine)

4-Demethoxy-3′-deamino-3′-aziridinyl-4′-methylsulphonyl-daunorubicin (PNU-159548): A promising new candidate for chemotherapeutic treatment of osteosarcoma patients

Cytotoxic α-bromoacrylic derivatives of distamycin analogues modified at the amidino moiety

Sequence-specific DNA alkylation of novel tallimustine derivatives

Influence of lipophilicity on cytotoxicity of anthracyclines in LoVo and LoVo/Dx human cell lines

Cytotoxic alpha-Bromoacrylic derivatives of low molecular weight

Doxorubicin Activity Is Enhanced by Hyperthermia in a Model of Ex Vivo Vascular Perfusion of Human Colon Carcinoma

4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms

Ring-B modified anthracyclines

Pharmacological and toxicological aspects of 4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548) : A novel antineoplastic agent

Cellular and molecular pharmacology of 4'-epidoxorubicin in HeLa cells: comparison with its parent drug, doxorubicin

DNA polymerases and DNA topoisomerases as targets for the development of anticancer drugs

Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivatives

Aktive Filter

Suchergebnisse filtern